PROACTA THERAPEUTICS
Proacta Therapeutics is a biopharmaceutical company, engages in the discovery and development of oncology drugs.
PROACTA THERAPEUTICS
Industry:
Biotechnology Oncology Pharmaceutical
Founded:
2001-01-01
Address:
Auckland, Auckland, New Zealand
Country:
New Zealand
Status:
Active
Contact:
+64 9 363 3322
Similar Organizations
Ablynx
Ablynx is a biopharmaceutical company engaged in the discovery and development of nanobodies.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
Lengo Therapeutics
Lengo Therapeutics a biopharmaceutical company focused on the discovery and development of cancer treatments.
multimmune GmbH
multimmune GmbH, a biopharmaceutical company, engages in the discovery and development of novel products.
OncoC4
OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for cancer treatment.
Proteomarine
Proteomarine is a pharmaceutical company that specializes in the search and development of new drugs.
Raze Therapeutics
Raze Therapeutics, Inc., a biotechnology company, engages in the discovery and development of oncology therapeutics.
TCD Pharma
TCD Pharma is a biotechnology company engaged in the discovery, development and commercialization of oncology drugs.
More informations about "Proacta Therapeutics"
Proacta - Crunchbase Company Profile & Funding
Proacta Inc. is a private, clinical-stage, biopharmaceutical company headquartered in San Diego, California. They are focused on addressing …See details»
Proacta Therapeutics Ltd. - VentureRadar
Proacta Therapeutics Ltd. VentureRadar profile. Find out more about Proacta Therapeutics Ltd. including the VentureRadar Innovation and Growth scores, Similar Companies and more. ...See details»
Proacta - Products, Competitors, Financials, Employees, …
Proacta is a clinical-stage, biopharmaceutical company focused on addressing unmet needs in the field of cancer with current efforts directed towards the development of hypoxia-activated …See details»
Proacta Therapeutics Limited Company Profile, Financial and
Proacta Therapeutics Limited, a biopharmaceutical company, engages in the discovery and development of oncology drugs. The company was incorporated in 2001 and is based in …See details»
Proacta Therapeutics - Crunchbase
Organization. Proacta Therapeutics . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. Similar Companies. ... Proacta Therapeutics and Lengo …See details»
Proacta - Ownership and Business Overview - Mergr
Proacta Therapeutics is developing a new generation of cancer drugs that uniquely target the physiological attributes of solid tumors. Proacta's first lead program, a hypoxia-targeted small …See details»
Proacta - VentureRadar
Proacta was founded on intellectual property generated in New Zealand at the University of Auckland and in the United States at Stanford University. Solid tumors and leukemia-infiltrated …See details»
Proacta | VentureRadar
Proacta Inc. is a private, clinical-stage, biopharmaceutical company headquartered in San Diego, California. We are focused on addressing unmet needs in the field of cancer with the …See details»
PROACTA THERAPEUTICS LIMITED - Profile, contacts and insights
Find key decision-makers, contacts, emails, headcount, share capital, recent funding, IPO status and other insights of PROACTA THERAPEUTICS LIMITED.See details»
Proacta - Products, Competitors, Financials, Employees, …
Proacta, founded in 2001, is a biotechnology company that discovers and develops innovative small-molecule prodrugs that address critical, unmet needs in oncology. Use the CB Insights …See details»
PROACTA Therapeutics Limited a new company developing novel …
Today Cancer Research Ventures (CRV) Limited, Auckland UniServices Limited and The Institute of Cancer Research, London, announced that they had formed a new company to develop …See details»
PROACTA Therapeutics Limited a new company developing novel …
On November 1, 2001 Cancer Research Ventures (CRV) Limited, Auckland UniServices Limited and The Institute of Cancer Research, London, reported that they had formed a new company …See details»
Proacta Labs - Company Profile - Tracxn
Oct 18, 2024 Proacta Labs - Clinical-stage company manufacturing a hypoxia-targeted small-molecule prodrug. Raised a total funding of $38.5M over 3 rounds from 7 investors. Founded …See details»
Proacta Therapeutics close to $12m deal for cancer trials
By SIMON COLLINS, science reporter Auckland University spinoff company Proacta Therapeutics is about to complete US$8 million ($12.4 million) in fundraising...See details»
Proacta raises $35M to fund its PR-104 development
Feb 19, 2007 Proacta, a clinical stage biotechnology company first founded in New Zealand, has completed a $35.0 million series B financing. The new funding will take the firm's lead …See details»
News - New cancer therapeutics company
A new cancer therapeutics company is being established by Auckland UniServices Ltd to draw on the research of scientists in Auckland and the United Kingdom. The company, Proacta …See details»
PROACTA Therapeutics Limited a new company developing novel …
Nov 1, 2001 Proacta plans to develop a certain number of its company proprietary prodrug candidates jointly with other parties as well as through an in-house drug development …See details»
Commercial Collaborations in Biotechnology | PPT - SlideShare
Dec 3, 2012 The case study of Proacta Therapeutics shows how collaborations can provide startups expertise and resources to commercialize their intellectual property. ... integrate …See details»
Series A Now Done, Proacta Has Funds To Fight Tumors
Feb 10, 2006 Proacta expects to start a separate trial in the middle of this year to assess the safety of the compound in combination with a standard chemotherapy agent. Preclinical …See details»
PROTAC development faces key preclinical testing hurdles
Dec 11, 2024 Moreover, partnering with an experienced preclinical testing organization provides the expertise and resources to navigate these complexities, streamline development, and …See details»